Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies

Journal of the American Society of Nephrology

Volumn 26, Issue 4, 2015, Pages 966-975

  Sawinski, Deirdre ^a   Forde, Kimberly A ^a,b   Trofe Clark, Jennifer ^a,c   Patel, Priyanka ^a   Olivera, Beatriz ^a   Goral, Simin ^a   Bloom, Roy D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; DONOR SPECIFIC ANTIBODY; HEPATITIS B SURFACE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BK VIRUS INFECTION; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT HISTORY OF KIDNEY TRANSPLANTATION; PERSISTENT INFECTION; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; BK VIRUS; BLOOD; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PENNSYLVANIA; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

ADULT; ANTIBODIES; BK VIRUS; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MIDDLE AGED; PENNSYLVANIA; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; VIREMIA;

EID: 84926453591     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014010119     Document Type: Article

References (21)

1. Gardner SD, Field AM, Coleman DV, Hulme B: New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1: 1253-1257, 1971
2. Dörries K: Molecular biology and pathogenesis of human polyomavirus infections. Dev Biol Stand 94: 71-79, 1998
3. Alméras C, Vetromile F, Garrigue V, Szwarc I, Foulongne V, Mourad G: Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients. Transpl Infect Dis 13: 101-108, 2011
4. Koukoulaki M, Grispou E, Pistolas D, Balaska K, Apostolou T, Anagnostopoulou M, Tseleni-Kotsovili A, Hadjiconstantinou V, Paniara O, Saroglou G, Legakis N, Drakopoulos S: Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis 11: 1-10, 2009
5. Thakur R, Arora S, Nada R, Minz M, Joshi K: Prospective monitoring of BK virus reactivation in renal transplant recipients in North India. Transpl Infect Dis 13: 575-583, 2011
6. Suwelack B, Malyar V, Koch M, Sester M, Sommerer C: The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen. Transplant Rev (Orlando) 26: 201-211, 2012
7. Dharnidharka VR, Cherikh WS, Abbott KC: An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation 87: 1019-1026, 2009
8. Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, Scheuermann EH, Klinger M, Russ G, Pescovitz MD, Prestele H: Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: A prospective, randomized, multicenter study. Am J Transplant 13: 136-145, 2013
9. Ramos E, Drachenberg CB, Papadimitriou JC, Hamze O, Fink JC, Klassen DK, Drachenberg RC, Wiland A, Wali R, Cangro CB, Schweitzer E, Bartlett ST, Weir MR: Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 13: 2145-2151, 2002
10. Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, Mihatsch MJ, Nickeleit V, Ramos E, Randhawa P, Shapiro R, Steiger J, Suthanthiran M, Trofe J: Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 79: 1277-1286, 2005
11. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM; Kidney Disease: Improving Global Outcomes: KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int 77: 299-311, 2010
12. Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice: BK polyomavirus in solid organ transplantation. Am J Transplant 13[Suppl 4]: 179-188, 2013
13. Schaub S, Hirsch HH, Dickenmann M, Steiger J, Mihatsch MJ, Hopfer H, Mayr M: Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant 10: 2615-2623, 2010
14. Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, Torrence S, Schuessler R, Roby T, Gaudreault-Keener M, Storch GA: Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5: 582-594, 2005
15. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC: BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant 10: 407-415, 2010
16. Elfadawy N, Flechner SM, Schold JD, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB: Transient versus persistent BK viremia and longterm outcomes after kidney and kidney-pancreas transplantation. Clin J Am Soc Nephrol 9: 553-561, 2014
17. Aiello FB, Calabrese F, Rigotti P, Furian L, Marino S, Cusinato R, Valente M: Acute rejection and graft survival in renal transplanted patients with viral diseases. Mod Pathol 17: 189-196, 2004
18. Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW: Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 12: 1157-1167, 2012
19. Everly MJ, Rebellato LM, Haisch CE, Ozawa M, Parker K, Briley KP, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI: Incidence and impact of de novo donor-specific alloantibody in primary renal allografts. Transplantation 95: 410-417, 2013
20. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J: Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347: 488-496, 2002
21. Thomas A, Dropulic LK, Rahman MH, Geetha D: Ureteral stents: A novel risk factor for polyomavirus nephropathy. Transplantation 84: 433-436, 2007